Á¤»ó¼³
À¯¹æ°©»ó¼±¾Ï¼¾ÅÍÀå
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : À¯¹æ
Á÷
ˤ
: ±³¼ö(À¯¹æ°©»ó¼±¾Ï¼¾ÅÍÀå)
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
6
ÇØ¿Ü
Giant cell malignant fibrous histiocytoma of the breast: a case report. : J Korean Med Sci 2004. Jun.
5
ÇØ¿Ü
Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. : Cancer Res 2001. Jul.
4
ÇØ¿Ü
Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast : WORLDJOURNALOFSURGICALONCOLOGY 2010.Apr.
3
ÇØ¿Ü
p53 as a specific prognostic factor in triple-negative breast cancer. : Japanese Journal of Clinical Oncology. 2009 Apr
2
ÇØ¿Ü
Bilateral chylothoraces without chyle leakage after left-sided neck dissection for thyroid cancer: reportof two cases. : Surgery Today 2007
1
ÇØ¿Ü
The HCCR Oncoprotein as a Biomaker for Human Breast Cancer : ClinicalCancerResearch 2005. Nov.
11
12
13
14
15
16
17
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729